Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mastec (MTZ) Common Equity: 2010-2025

Historic Common Equity for Mastec (MTZ) over the last 15 years, with Sep 2025 value amounting to $3.2 billion.

  • Mastec's Common Equity rose 12.40% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 12.40%. This contributed to the annual value of $3.0 billion for FY2024, which is 9.78% up from last year.
  • Per Mastec's latest filing, its Common Equity stood at $3.2 billion for Q3 2025, which was up 5.47% from $3.0 billion recorded in Q2 2025.
  • In the past 5 years, Mastec's Common Equity ranged from a high of $3.2 billion in Q3 2025 and a low of $2.1 billion during Q1 2021.
  • In the last 3 years, Mastec's Common Equity had a median value of $2.7 billion in 2024 and averaged $2.8 billion.
  • Its Common Equity has fluctuated over the past 5 years, first climbed by 26.84% in 2021, then dropped by 0.73% in 2023.
  • Over the past 5 years, Mastec's Common Equity (Quarterly) stood at $2.5 billion in 2021, then climbed by 7.76% to $2.7 billion in 2022, then decreased by 0.73% to $2.7 billion in 2023, then increased by 9.78% to $3.0 billion in 2024, then rose by 12.40% to $3.2 billion in 2025.
  • Its Common Equity stands at $3.2 billion for Q3 2025, versus $3.0 billion for Q2 2025 and $3.0 billion for Q1 2025.